Bid­ding to be the go-to ge­nomics and da­ta part­ner for drug de­vel­op­ment, Sophia Ge­net­ics rais­es $100M

Ju­r­gi Cam­b­long has spent the last decade go­ing from mi­nor fund­ing round to mi­nor fund­ing round for his start­up, Sophia Ge­net­ics, adding hos­pi­tals in the UK, US, and Latin Amer­i­ca and ex­pand­ing the plat­form to han­dle more and more da­ta. Now, Cam­b­long says, the com­pa­ny has spread far enough and has now raised plen­ty of cash to clear one of its last hur­dles.

In the sixth and largest fund­ing round in their 9-year his­to­ry, Sophia Ge­net­ics has raised $110 mil­lion to push for­ward its AI-based plat­form for ge­net­ic med­i­cine with a re­newed fo­cus on tak­ing their es­tab­lished in­fra­struc­ture and us­ing it help bio­phar­ma col­lect ev­i­dence and de­sign tri­als. The round was led the Is­raeli firm aMoon and the Japan­ese firm Hi­tachi Ven­tures.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.